Macrogenics (MGNX) Misses Q2 EPS by 23c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
MacroGenics (MGNX) PT Lowered to $6 at Stifel
August 7, 2024 10:18 AM EDTStifel analyst Stephen Willey lowered the price target on MacroGenics (NASDAQ: MGNX) to $6.00 (from $7.00) while maintaining a Hold rating.
The analyst comments "Our Hold-rated thesis on MGNX shares remains unchanged following managements earnings announcement and corporate update. While the presentation of... More



